1350P Phase I/II trial shows promising efficacy of nadunolimab in combination with platinum doublet as second-line therapy in patients with NSCLC
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1405
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
1
Citations
1
h-index
0
i10-index
Z. Zvirbule is an academic researcher from Riga East University Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 1, co-authored 5 publications.
https://doi.org/10.1016/j.annonc.2024.08.1405
https://doi.org/10.1016/j.iotech.2024.100772
Click to start Chat